Illumina, Inc. (ILMN)
Illumina, Inc. (ILMN) is a Healthcare stock tracked by StreetAlpha. ILMN reports earnings on Thu, Oct 29, 2026. The average 12-month price target from 12 analysts is $238.17, with a high of $310.00 and a low of $113.00. Analyst consensus is Buy, based on the latest ratings from 12 firms (8 buy, 2 hold, 2 sell). Over the past 90 days StreetAlpha recorded 5 whale options trades in ILMN, 40% of them bullish and 60% bearish. In the past 30 days there were 14 dark pool prints totaling $22.3M, the largest $5.1M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 12 analysts who set a price target on ILMN in the past 90 days. The average target is $238.17, with a high of $310.00 and a low of $113.00.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 5 | RBC Capital | Target raised | Buy | $230 → $310 |
| Oct 1 | Guggenheim | Target raised | Buy | $226 → $305 |
| Sep 29 | Leerink Partners | Target raised | Buy | $210 → $300 |
| Sep 28 | Piper Sandler | Target raised | Buy | $225 → $305 |
| Sep 9 | UBS | Upgrade | Buy | $260 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ILMN is in one of them and how their past ILMN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ILMN in an article yet. Here's the latest on the wider market.